IFITM5 pathogenic variant causes osteogenesis imperfecta V with various phenotype severity in Ukrainian and Vietnamese patients

被引:16
作者
Zhytnik, Lidiia [1 ]
Maasalu, Katre [1 ,2 ]
Duy, Binh Ho [3 ]
Pashenko, Andrey [4 ]
Khmyzov, Sergey [4 ]
Reimann, Ene [5 ,6 ]
Prans, Ele [6 ]
Koks, Sulev [7 ]
Martson, Aare [1 ,2 ]
机构
[1] Univ Tartu, Dept Traumatol & Orthopead, Puusepa 8, EE-51014 Tartu, Estonia
[2] Tartu Univ Hosp, Clin Traumatol & Orthopead, Puusepa 8, EE-51014 Tartu, Estonia
[3] Hue Univ, Hue Univ Med & Pharm, Hue, Vietnam
[4] AMS Ukraine, Sytenko Inst Spine & Joint Pathol, Dept Pediat Orthoped, Pushkinska 80, UA-61024 Kharkov, Ukraine
[5] Univ Tartu, Ctr Translat Med, Ravila 14a, EE-50411 Tartu, Estonia
[6] Univ Tartu, Dept Pathophysiol, Ravila 19, EE-50411 Tartu, Estonia
[7] QEII Med Ctr, Perron Inst Neurol & Translat Sci, Nedlands, WA, Australia
基金
欧盟地平线“2020”;
关键词
Osteogenesis imperfecta; IFITM5; Type V; Hyperplastic callus; Bone fragility; CLINICAL-DIAGNOSIS; GENOTYPE-PHENOTYPE; MUTATIONS; HETEROGENEITY; VARIABILITY; FEATURES; 5'-UTR; FORM;
D O I
10.1186/s40246-019-0209-3
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
BackgroundOsteogenesis imperfecta (OI) covers a spectrum of bone fragility disorders. OI is classified into five types; however, the genetic causes of OI might hide in pathogenic variants of 20 different genes. Often clinical OI types mimic each other. This sometimes makes it impossible to identify the OI type clinically, which can be a risk for patients. Up to 90% of OI types I-IV are caused by pathogenic variants in the COL1A1/2 genes. OI type V is caused by the c.-14C>T pathogenic variant in the 5UTR of the IFITM5 gene and is characterized by hyperplastic callus formation and the ossification of interosseous membranes.ResultsIn the current study, we performed IFITM5 5UTR region mutational analysis using Sanger sequencing on 90 patients who were negative for COL1A1/2 pathogenic variants. We also investigated the phenotypes of five patients with genetically confirmed OI type V. The proportion of OI type V patients in our cohort of all OI patients was 1.48%. In one family, there was a history of OI in at least three generations. Phenotype severity differed from mild to extremely severe among patients, but all patients harbored the same typical pathogenic variant. One patient had no visible symptoms of OI type V and was suspected to have had OI type IV previously. We also identified a case of extremely severe hyperplastic callus in a 15-year-old male, who has hearing loss and brittleness of teeth.ConclusionsOI type V is underlined with some unique clinical features; however, not all patients develop them. The phenotype spectrum might be even broader than previously suspected, including typical OI features: teeth brittleness, bluish sclera, hearing loss, long bones deformities, and joint laxity. We suggest that all patients negative for COL1A1/2 pathogenic variants be tested for the presence of an IFITM5 pathogenic variant, even if they are not expressing typical OI type V symptoms. Further studies on the pathological nature and hyperplastic callus formation mechanisms of OI type V are necessary.
引用
收藏
页数:11
相关论文
共 44 条
  • [1] Genotype-phenotype study in type V osteogenesis imperfecta
    Balasubramanian, Meena
    Parker, Michael J.
    Dalton, Ann
    Giunta, Cecilia
    Lindert, Uschi
    Peres, Luiz C.
    Wagner, Bart E.
    Arundel, Paul
    Offiah, Amaka
    Bishop, Nicholas J.
    [J]. CLINICAL DYSMORPHOLOGY, 2013, 22 (03) : 93 - 101
  • [2] CRTAP and LEPRE1 Mutations in Recessive Osteogenesis Imperfecta
    Baldridge, Dustin
    Schwarze, Ulrike
    Morello, Roy
    Lennington, Jennifer
    Bertin, Terry K.
    Pace, James M.
    Pepin, Melanie G.
    Weis, MaryAnn
    Eyre, David R.
    Walsh, Jennifer
    Lambert, Deborah
    Green, Andrew
    Robinson, Haynes
    Michelson, Melonie
    Houge, Gunnar
    Lindman, Carl
    Martin, Judith
    Ward, Jewell
    Lemyre, Emmanuelle
    Mitchell, John J.
    Krakow, Deborah
    Rimoin, David L.
    Cohn, Daniel H.
    Byers, Peter H.
    Lee, Brendan
    [J]. HUMAN MUTATION, 2008, 29 (12) : 1435 - 1442
  • [3] DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: diagnostic yield and mutation spectrum
    Bardai, G.
    Moffatt, P.
    Glorieux, F. H.
    Rauch, F.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2016, 27 (12) : 3607 - 3613
  • [4] Exome Sequencing Identifies Truncating Mutations in Human SERPINF1 in Autosomal-Recessive Osteogenesis Imperfecta
    Becker, Jutta
    Semler, Oliver
    Gilissen, Christian
    Li, Yun
    Bolz, Hanno Joern
    Giunta, Cecilia
    Bergmann, Carsten
    Rohrbach, Marianne
    Koerber, Friederike
    Zimmermann, Katharina
    de Vries, Petra
    Wirth, Brunhilde
    Schoenau, Eckhard
    Wollnik, Bernd
    Veltman, Joris A.
    Hoischen, Alexander
    Netzer, Christian
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2011, 88 (03) : 362 - 371
  • [5] BYERS PH, 1992, ANNU REV MED, V43, P269, DOI 10.1146/annurev.me.43.020192.001413
  • [6] Natural history of hyperplastic callus formation in osteogenesis imperfecta type V
    Cheung, Moira S.
    Glorieux, Francis H.
    Rauch, Frank
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (08) : 1181 - 1186
  • [7] A Single Recurrent Mutation in the 5′-UTR of IFITM5 Causes Osteogenesis Imperfecta Type V
    Cho, Tae-Joon
    Lee, Kyung-Eun
    Lee, Sook-Kyung
    Song, Su Jeong
    Kim, Kyung Jin
    Jeon, Daehyun
    Lee, Gene
    Kim, Ha-Neui
    Lee, Hye Ran
    Eom, Hye-Hyun
    Lee, Zang Hee
    Kim, Ok-Hwa
    Park, Woong-Yang
    Park, Sung Sup
    Ikegawa, Shiro
    Yoo, Won Joon
    Choi, In Ho
    Kim, Jung-Wook
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2012, 91 (02) : 343 - 348
  • [8] Genetic analysis of osteogenesis imperfecta in the Palestinian population: molecular screening of 49 affected families
    Essawi, Osama
    Symoens, Sofie
    Fannana, Maha
    Darwish, Mohammad
    Farraj, Mohammad
    Willaert, Andy
    Essawi, Tamer
    Callewaert, Bert
    De Paepe, Anne
    Malfait, Fransiska
    Coucke, Paul J.
    [J]. MOLECULAR GENETICS & GENOMIC MEDICINE, 2018, 6 (01): : 15 - 26
  • [9] Fitzgerald Jamie, 2013, J Rare Disord, V1, P37
  • [10] Fratzl-Zelman N, 2015, WIEN MED WOCHENSCHR, V165, P264, DOI 10.1007/s10354-015-0368-3